Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of COX-2 Inhibition on Allergen-induced Airway Obstruction in Subjects With Asthma

NCT01002690 is registered in ClinicalTrials.gov with Barbro Dahlen as lead sponsor.

NCT NCT01002690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01002690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of COX-2 Inhibition on Allergen-induced Airway Obstruction in Subjects With Asthma
Lead sponsor
Barbro Dahlen
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2009
Completion date
April 30, 2012
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma